“Hepatitis B infection”的搜索结果，显示 481-490 项，共有 9398 项

1. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

2. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

3. 血液科- 临床试验- 妙佑医疗国际

   Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...

4. MELD（终末期肝病模型）评分 - 医生与科室- 妙佑医疗国际

   B. Minnesota. Ilyas, Sumera I. M.B.B.S.. Minnesota ... BMC Infectious Diseases. 2017; doi:10.1186 ... hepatitis/itt-20434719. Accessed Aug. 20, 2025 ...

5. 血液科- 临床试验- 妙佑医疗国际

   ... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) As Monotherapy And In Combination, For Treatment Of Patients With Indolent Non-Hodgkin Lymphoma.

6. 皮肤 B 细胞淋巴瘤- 症状与病因

   详细了解这种类型的非霍奇金淋巴瘤的症状、诊断和治疗方法。

7. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

8. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

9. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

10. 血液科- 临床试验- 妙佑医疗国际

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...